StockData
Precision BioSciences Inc logo

Precision BioSciences Inc (DTIL) stock

DTILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends May 21
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/3058% above fair value
$7.10+0.05 (+0.71%)

Close on Nov 18, 2026Market cap $195.97MP/E –Yield –

Precision BioSciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Precision BioSciences's market cap was $241.87M on Nov 11, 2026, against $65.73M a year earlier. Over the last 5 years it ranged from $28.50M to $444.65M, with a median of $83.14M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$241.87M+381.2%
2025Dec 31, 2025$50.26M+76.4%
2024Dec 31, 2024$28.50M-32.5%
2023Dec 29, 2023$42.23M-68.0%
2022Dec 30, 2022$132.03M-70.3%
2021Dec 31, 2021$444.65M+1.6%
2020Dec 31, 2020$437.69M-37.8%
2019Dec 31, 2019$703.73M–

More Precision BioSciences figures

See a number that looks wrong?